Michael J. Stratton

Michael J. Stratton is a renowned scientist specializing in cancer research, focusing on understanding the genetic changes that lead to tumor development. His work involves studying how mutations in DNA contribute to cancer, with the goal of identifying targeted treatments. Stratton’s research has advanced knowledge of cancer genetics and helped develop personalized medicine approaches, improving diagnosis and therapy options. He holds prominent positions at the Wellcome Sanger Institute and University of Cambridge, contributing significantly to the scientific community’s efforts to combat cancer through innovative genomic studies.